CN1778344B - Medicine for treating coronary heart disease - Google Patents

Medicine for treating coronary heart disease Download PDF

Info

Publication number
CN1778344B
CN1778344B CN 200410072949 CN200410072949A CN1778344B CN 1778344 B CN1778344 B CN 1778344B CN 200410072949 CN200410072949 CN 200410072949 CN 200410072949 A CN200410072949 A CN 200410072949A CN 1778344 B CN1778344 B CN 1778344B
Authority
CN
China
Prior art keywords
ultrafiltration
film
membrane
chinese medicine
salviae miltiorrhizae
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN 200410072949
Other languages
Chinese (zh)
Other versions
CN1778344A (en
Inventor
李旭
郑永锋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tasly Pharmaceutical Group Co Ltd
Original Assignee
Tianjin Tasly Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tianjin Tasly Pharmaceutical Co Ltd filed Critical Tianjin Tasly Pharmaceutical Co Ltd
Priority to CN 200410072949 priority Critical patent/CN1778344B/en
Publication of CN1778344A publication Critical patent/CN1778344A/en
Application granted granted Critical
Publication of CN1778344B publication Critical patent/CN1778344B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Separation Using Semi-Permeable Membranes (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

A Chinese medicine for treating coronary heart disease is prepared from red sage root, notoginseng and dalbergia wood oil or storax is prepared through extracting the liquid extract from red sage root and notoginseng in water or alcohol, clarifying, ultrafiltering, concentrating, adding dalbergia wood oil or storax and shaping.

Description

The medicine of treatment coronary heart disease
Technical field
The present invention relates to a kind of Chinese medicine composition of using the ultrafiltration technology preparation.Particularly, the present invention relates to a kind of Chinese medicine composition of using the ultrafiltration technology preparation.
Background technology
Membrane separation technique (Membrane Separation Technique) is an emerging high efficient separation technology, by internationally recognized be a most rising great high production tech of mid-term 20 end of the centurys to 21 century.Ultrafiltration (U1trafiltration, UF) technology is a kind of membrane separation technique, its ultimate principle is to utilize fenestra selectivity sieve performance, with separation, purification and condensed matter.Hyperfiltration process is that the anisotropic membrane (being asymmetric membrane) that utilizes macromolecular material to make is a filter medium, under normal temperature condition, relies on certain pressure and flow velocity, makes flow of solution through face, forces low molecular weight substance to see through film, and polymer substance is trapped.
Because hyperfiltration process is a physical method; do not have and must heat repeatedly; there be not " phase " to change; the probability of destroying effective ingredient is few than other universal method; characteristics such as technological process is short; thereby its be applied to extract in the research of pharmaceutically active ingredient become increasingly active; portioned product moves towards commercial production from laboratory research. and human ultrafiltrations such as 304 Wang Shiling of hospital of PLA are extracted effective ingredient baicalin in the Radix Scutellariae; the result shows that ultrafiltration is at productive rate; the purity aspect is excellent than well-established law all; and a ultrafiltration can reach the injection requirement; do not need again row refining; technology is simple; production cycle can shorten 1~2 times of (Wang Shiling; Zheng Dianbao " ultrafiltration is extracted the preliminary investigation of baicalin "; Chinese patent medicine research; 1988 (3): 5). Wang Shiling etc. have also further studied the optimum process condition of ultrafiltration extraction baicalin; it is the key that improves baicalin yield and quality that the experimental result proof is selected the ultrafilter membrane in suitable aperture (molecular cut off is 6000~10000) for use; the fluid temperature that raises simultaneously or reduction concentration; strict control pH value (pH=1.5 during acidify; pH=7.0 when alkali is molten); can significantly improve ultrasiltrated rate; obtain best output effect (Wang Shiling; " ultrafiltration is once extracted the technical study of baicalin "; Chinese patent medicine; 1994; 16 (3): 2). Xu Jinlin etc. are with ultrafiltration (polysulfone membrane; molecular cut off 6000) is used for the preparation of phytic acid; the phytic acid yield is 86.4%, and than the phytate method raising 12.6% of routine, and ultrafiltration gained phytic acid contains Phos hardly; appearance transparent is close to colourless (Xu Jinlin; Xu Jie, Wang Yuanjin " membrane separation technique prepares the research of phytic acid ", Chinese Journal of Pharmaceuticals; 1994; 25 (4): 150). He Changsheng etc. use hyperfiltration technique separation and purification steviol glycosides, and adopting ultrathin plate-type hyperfiltration device and molecular cut off is that 10000 cellulose acetate membrane (CA film) purifies field experimentation to steviol glycosides, and its technological process is rationally feasible. the ultrafilter stable performance; the decoloration performance and the removal of impurity of film are respond well; bubble problem (He Changsheng, WangBing Nan, Zhu Shanshan " applied research of steviol glycosides ultrafiltration " in the time of can solving precipitation that steviol glycosides usually occurs in producing and embedding preferably; water technology; 1994,20 (2): 89). Huang is improved oneself and is adopted the refining sasanguasaponin of ultrafilter membrane (molecular cut off is 4000 and 10000 polysulfone membrane), with the domestic bleaching that mostly adopts; the recrystallize method; the alcohol ether sedimentation method and the basic salt sedimentation method are relatively; the ultrafiltration flow process is simple; the efficient height, expense is low, to removing the oils and fats in the thick sasanguasaponin; pigment; saccharide and the strong impurity of other hydrophilic; can both producing a desired effect, (Huang is improved oneself; " ultrafiltrationmembrane process is made with extra care the sasanguasaponin pre-test " water technology, 1995,21 (2): 99). Guo Li Wei of Nanjing University of Traditional Chinese Medicine etc. has relatively studied water alcohol method and ultrafiltration is clarified the influence of Fructus Corni preparation to its preparation ingredient; the result confirms that ultrafiltration is more effective to saccharide impurity in the removal medicinal liquid; molecular cut off is that 10000 ultrafilter membrane does not have obviously influence to meliatin (molecular weight is 384), makes meliatin loss about 50% (Guo Liwei, Peng Guoping but molecular cut off is 1000 film; Pan Yang etc. " the refining comparative study that contains the Fructus Corni Chinese medicine preparation of water alcohol method and membrane separation process "; Chinese patent medicine, 1999,21 (2): 59). Wang Chengzhang etc. adopt ultrafiltration (polysulfone membrane; molecular cut off 30000) separates with the ethanol extract of polyamide absorb-elute method Folium Ginkgo; purification; detect through high performance liquid chromatography (HPLC), the ginkgetin salidroside content is about 45%, and yield is 0.5%~0.7%; more conventional steam distillation; the organic solvent extraction method is excellent; and in ultrafiltration technology, can reduce discharge of wastewater, the protection environment reduces production costs; (Wang Chengzhang increases economic efficiency; Yu Qing, Tan Weihong etc. " application of ultrafiltration in purification Folium Ginkgo flavone glycoside ", forestry science and technology communication; 1997, (2): 21).
Though hyperfiltration technique is applied to the production of Chinese medicine preparation its unique advantage is arranged, its degree of applying is still very limited, traces it to its cause, and remains in following problem:
(1) medicinal herb components complexity, particularly many compound preparations, effective ingredient are also unclear fully, therefore need to carry out very deep research before hyperfiltration technique is applied to Chinese herbal and crude drugs preparations.For example because the complexity of composition, do not carry out a large amount of pharmacology and clinical research test fully estimate ultrafiltration to Chinese medicine preparation in before the drug effect influence degree of each composition, ultrafiltration can not be applied to the production of most of Chinese medicine preparation.
(2) kind of membrane material is few, and membrane aperture distributes wide, and performance is understable.Used ultrafilter membrane material has cellulose acetate, polyacrylonitrile, polysulfones, SPSF, polysulfonamides etc. in Chinese medicine preparation production.By its affinity classification, be broadly divided into two classes: hydrophobic film material and hydrophilic film material to water.Hydrophilic film such as cellulose acetate, SPSF material is few to solute absorption, and molecular cut off is less, but poor heat stability, mechanical strength, chemical proof, antibacterium erosiveness are not high usually; Hydrophobic film materials such as polysulfones, the mechanical strength height, high temperature resistant, anti-solvent, anti-biodegradation, but because of containing a large amount of hydrophobicity genes or chain link in the strand, and have more electrostatic charge, thereby the permeable speed of film is low, contamination resistance is lower.
(3) pollution problem of film is to hinder hyperfiltration technique is moved towards the commercial Application stage by laboratory research biggest obstacle.In the ultra-filtration process of Chinese medicine preparation, when not good as if the medicinal liquid pretreating effect, face easily pollutes, and fenestra stops up, and making permeation flux is that productivity ratio descends, even cisco unity malfunction, and production efficiency reduces, and cost rises, and causes the shortening in service life of film.
(4) system of selection of membrane module is not set up as yet, the optimization of still needing of ultrafiltration parameter.The factor that influences the ultrafiltration effect is a lot, comprises the selection of membrane module, the cleaning method after the definite and ultrafilter of technological parameter uses etc.Therefore be applicable to ultrafiltration apparatus and the operating procedure that the ultrafiltration of Chinese medicine system is used, remain further to be studied.
The inventor by a large amount of experimental datas are analyzed, has determined suitable process condition, for the suitability for industrialized production of utilizing ultrafiltration to carry out medicine of the present invention provides concrete solution through the effort of long-term and unremitting ground.
Summary of the invention
The purpose of this invention is to provide the Chinese medicine of ultrafiltration preparation technology's preparation that a kind of impurity is few, loss of effective components is little, cost is low, it has overcome the deficiencies in the prior art, has solved the difficult problem of suitability for industrialized production ultrafiltration technology condition operability.
The present invention realizes by following technical step: with Radix Salviae Miltiorrhizae, Radix Notoginseng and Lignum Dalbergiae Odoriferae oil is crude drug, is prepared according to following steps:
(1) with Radix Salviae Miltiorrhizae, panax mixed or make water extract or alcohol extract respectively separately;
(2) described extracting solution being carried out predefecation handles;
(3) further described extracting solution is carried out hyperfiltration treatment;
(4) ultrafiltrate is concentrated, add Lignum Dalbergiae Odoriferae oil, make preparation according to a conventional method.
The percentage by weight of above-mentioned raw materials medicine is: Radix Salviae Miltiorrhizae 20%~97%, Radix Notoginseng 2%~79%, Lignum Dalbergiae Odoriferae oil 0.2%~3%; Be preferably Radix Salviae Miltiorrhizae 63.0%%~94%, Radix Notoginseng 4.0%~35.0%, Lignum Dalbergiae Odoriferae oil 0.5%~2.0%; More preferably Radix Salviae Miltiorrhizae 75.2%~90%, Radix Notoginseng 9%~23.5%, Lignum Dalbergiae Odoriferae oil 0.5%~1.3%.The percentage by weight sum of Radix Salviae Miltiorrhizae, Radix Notoginseng, Lignum Dalbergiae Odoriferae oil is 100%.
The above-mentioned raw materials Lignum Dalbergiae Odoriferae can be replaced with Styrax, and promptly the above-mentioned raw materials medicine can be Radix Salviae Miltiorrhizae 20%~97%, Radix Notoginseng 2%~79%, Styrax 0.2%~3%; Be preferably Radix Salviae Miltiorrhizae 63.0%%~94%, Radix Notoginseng 4.0%~35.0%, Styrax 0.5%~2.0%; More preferably Radix Salviae Miltiorrhizae 75.2%~90%, Radix Notoginseng 9%~23.5%, Styrax 0.5%~1.3%.The percentage by weight sum of Radix Salviae Miltiorrhizae, Radix Notoginseng, Styrax is 100%.
In the technology of the present invention step (1), alcohol extract can be the extracting solution of the lower alcohol of variable concentrations such as methanol, ethanol, normal propyl alcohol, isopropyl alcohol, n-butyl alcohol, isobutanol etc. or the extracting solution of its mixture.Carrying out next step predefecation after alcohol extract can not concentrate or suitably concentrate handles.
In the technology of the present invention step (2), preliminary clarifying treatment can be carried out coarse filtration with general material such as gauze, tiffany etc., the also available material such as the ceramic membrane of specialty carry out microfiltration, also can behind high speed centrifugation, divide and get supernatant, adsorption clarifications such as also available flocculating agent such as flocculate with chitosan clarifier, 101 fruit juice clarifiers, ZTC1+1 natural clarifying agent, Ovum Gallus domesticus album flocculating agent and remove particle bigger in the medicinal liquid, also available alcohol deposition method is removed most impurity.Both can singly use above-mentioned defecation method, but also use in conjunction, coarse filtration-adsorption clarification for example, adsorption clarification-high speed centrifugation, coarse filtration-microfiltration, coarse filtration-precipitate with ethanol etc.After can not concentrating or suitably concentrate, the solution that predefecation is handled carries out next step ultrafiltration; Preferably do not concentrate the ultrafiltration of promptly carrying out next step.
In the technology of the present invention step (3), the used ultrafilter membrane of ultrafiltration can be cellulose diacetate film (CA), three cellulose acetate membrane (CTA), cyanoethyl cellulose film (CN-CA), polysulfone membrane (PS), sulfonated polysulfone membrane (SPS), poly (ether sulfone) film (PES), sulfonated polyether sulfone film (SPES), polysulfonamides film (PSA), phenolphthalein side group polyarylsulfone (PAS) film (PDS), polyvinylidene fluoride film (PVDF), polyacrylonitrile film (PAN), polyimide film (N), cellulose membrane, methyl methacrylate-acrylonitrile copolymer film (MMA-AN), polyacrylonitrile/cellulose diacetate (PAN/CA) blend film, the dynamically ultrafilter membrane that forms, and the Modified Membrane of above-mentioned film.Be preferably cellulose diacetate film (CA), three cellulose acetate membrane (CTA), polysulfone membrane (PS), sulfonated polysulfone membrane (SPS), poly (ether sulfone) film (PES), sulfonated polyether sulfone film (SPES), polysulfonamides film (PSA), polyvinylidene fluoride film (PVDF), polyacrylonitrile film (PAN).
The molecular cut off of above-mentioned ultrafilter membrane is generally 6000~80000, is preferably 10000~70000, and the best is 20000~50000.
Ultrafiltration both can be adopted cross flow filter, also can adopt dead-end filtration, but preferred cross flow filter.
The operating condition of ultrafiltration technology is as follows:
(1) the inlet pressure of ultrafiltration is 0.1~0.5MPa, is preferably 0.1~0.35Mpa, and the best is 0.25~0.35Mpa; The liquid outlet pressure ratio inlet pressure of ultrafiltration hangs down 0.5~0.25kPa.The ultrafiltration initial stage is adopted lower pressure, slowly boosts then; In ultra-filtration process, adopt the periodic pressure fluctuation, the pressure wave moment is 0.1~0.2Mpa.
(2) the feed liquid flow velocity is 1.0~4.0m/s, is preferably 2.0~3.0m/s.In the ultra-filtration process, adopt the fluctuation of periodicity flow so that produce pulsating flow or non-stationary flow in membrane channels, the flow speed wave moment is 1.0~2.0m/s.
(3) feed high-pressure inert gas such as nitrogen in the ultrafiltration system discontinuous, form the gas-liquid stream of pulses, the cycle is that 0.5h~2h ventilates once, each 1 minute.
(3) feed temperature is 15~50 ℃, is preferably 20~40 ℃.
(4) when feed liquid stock solution is concentrated 1/15~1/5, add water or dilute alcohol solution ultrafiltration 1~2 time again; Be preferably when feed liquid stock solution is concentrated 1/12~1/8, add water or dilute alcohol solution ultrafiltration 1~2 time again.
(5) pH value of feed liquid is controlled at 5~9, is preferably 6.0~7.5;
(6) backwash condition: backwashing pressure is 0.15~2.5MPa, backwashing period is that 0.5~1.5h, backwashing time are that 1min~10min. is when replacing the method for recoil with ultrafiltration module use in parallel, wherein a cover or a few cover carry out normal ultrafiltration and distribute the recoil ultrafilter membrane of another set of or several grip assemblies of a part of filtrate, exchange is carried out behind the certain interval of time, generally be work 10~20min, recoil 30sec~3min.
(7) the Chemical cleaning cycle is 0.5 month~February, the Chemical cleaning medicament is generally diluted acid, diluted alkaline, surfactant, be preferably diluted alkaline, 0.5%~4.0% sodium hydroxide for example, the mixed solution of 1.5% sodium hydroxide and 2% sodium hypochlorite etc., pH value is 10~12, and cleaning pressure is 0.05~1.0MPa.After cleaning with chemical, the flushing of reuse water is near neutral.
In ultra-filtration process, both periodic pressure oscillation or the fluctuation of periodicity flow or periodicity fed noble gas separately, also can unite use, be periodic pressure fluctuation and periodically flow fluctuation associating use, perhaps the periodic pressure fluctuation is with periodically feeding noble gas unites use, perhaps periodically the flow fluctuation is with periodically feeding noble gas unites use, and perhaps the three unites use together.
In the technology of the present invention step (4), ultrafiltrate is condensed into extractum after, make preparation more according to a conventional method.For example, can be mixed and made into tablet, capsule, granule, oral liquid, slow releasing preparation, controlled release preparation, gel, ointment, ointment, cream, suppository, injection, injectable powder, patch, drop pill, suspensoid or the like with adjuvant on any or more than one pharmaceuticss such as starch, dextrin, lactose, microcrystalline Cellulose, hydroxypropyl methylcellulose, Polyethylene Glycol, magnesium stearate, micropowder silica gel, xylitol, lactose, glucose, glycine, mannitol, glycine etc.
The clinical observation of experimental example Drug therapy angina pectoris of the present invention
1 data and method
1.1 case is selected
" name of ischemic heart desease and the diagnostic criteria " that the angina pectoris diagnostic criteria of all cases is formulated with reference to WHO, symptom such as that the patient has is uncomfortable in chest, feel suffocated, but through having a rest or sublingual administration nitroglycerin relief of symptoms.Include 120 examples altogether in, be divided into two groups in proper order according to patient's prescription on individual diagnosis by 2: 1.80 examples are organized in treatment, male 51 examples, women 29 examples, year at age (55 ± 9), the course of disease (5.1 ± 1.3) year.Matched group 40 examples, male 29 examples, women 11 examples, year at age (55 ± 6), the course of disease (3.2 ± 1.1) year.Two groups of patients in sex, age, course of disease constituent ratio through x 2Or t check P>0.05, have comparability.
1.2 administrated method
The treatment group is taken medicine of the present invention (tablet), and each 3, every day 3 times.Matched group is given sorbitrate, each 10mg, every day 3 times, sublingual administration nitroglycerin in case of necessity.Be 2 months two groups of courses of treatment.
All do blood, routine urinalysis, liver, renal function, blood fat, blood glucose, Electrocardioscopy before and after the case treatment, write down the angina pectoris attacks number of times weekly, detect electrocardio, blood pressure, and inquiry adverse effect.
2 efficacy assessment standards
Judgement angina pectoris and ECG curative effect are all evaluated by " the medicine for cardiovascular system clinical research guideline " of bureau of drug administration of Ministry of Health of the People's Republic of China promulgation in 1993.The angina pectoris symptom curative effect determinate standard: produce effects, equal tired degree do not cause that angina pectoris or angina pectoris attacks number of times reduce more than 80%, and the nitroglycerin consumption reduces 80%; Effectively: angina pectoris attacks number of times and nitroglycerin consumption all reduce 50%~80%; Invalid: angina pectoris attacks number of times and nitroglycerin consumption all reduce less than 50%; Increase the weight of: angina pectoris attacks number of times, degree and persistent period increase, and the nitroglycerin consumption increases.
ECG curative effect criterion: produce effects: transference cure, electrocardiogram check ST section and T ripple recover normal, and exercise test transfers feminine gender to by the positive; Effectively: sx, electrocardiogram check ST section is low flat, and the T ripple is inverted to some extent and is corrected; Invalid: symptom basic with treatment before identical, the low flat or T ripple of electrocardiogram check ST section is inverted not improvement.
3 observed results
3.1 symptom and ECG curative effect (seeing Table 1)
Table 1 a liang group medicine compares angina pectoris symptom and ECG curative effect
Two groups of symptom curative effects, obvious effective rate is analyzed through Ridit, P<0.05; Two groups of ECG curative effect, obvious effective rate is analyzed through Ridit, P<0.05, the treatment group obviously is better than matched group.
3.2 the comparison (seeing Table 2) of heart rate and blood pressure before and after two groups of Drug therapys
The variation comparison of heart rate blood pressure before and after the table 2 liang group Drug therapy (x ± s)
Figure G2004100729499D00062
Treatment front and back self paired t-test, t check between group group of P<0.05, two, P<0.05.
3.3 other
The blood fat of treatment group and matched group, blood glucose, liver function, renal function all change not quite before and after being determined at treatment.
The specific embodiment
The invention will be further elaborated below in conjunction with embodiment.These embodiment only are used to the purpose that exemplifies, rather than limit the present invention by any way.
Embodiment one
Crude drug adopts Radix Salviae Miltiorrhizae 450g, Radix Notoginseng 141g, Lignum Dalbergiae Odoriferae oil 8g.
Obtain the ethanol extract of Radix Salviae Miltiorrhizae with the ethanol extraction Radix Salviae Miltiorrhizae, with gauze with this extracting liquid filtering, collect filtrate. filtrate is that 6000 cellulose diacetate film carries out ultrafiltration with molecular cut off, filter type adopts cross flow filter. and the operating condition of ultrafiltration technology is: the inlet pressure of ultrafiltration is 0.1Mpa, the low 0.5kPa. ultrafiltration initial stage of the liquid outlet pressure ratio inlet pressure of ultrafiltration is adopted lower pressure, slowly boosts then; In ultra-filtration process, the fluctuation of employing periodic pressure, the pressure wave moment is that 0.1Mpa. feed liquid flow velocity is 1.0m/s, in the ultra-filtration process, adopt periodically flow fluctuation so that in membrane channels, produce pulsating flow or non-stationary flow, the flow speed wave moment is 1.0m/s, feed nitrogen in the ultrafiltration system discontinuous, form the gas-liquid stream of pulses, cycle is that 0.5h ventilates once, each 1 minute. feed temperature is 15 ℃, when feed liquid stock solution is concentrated 1/15, add water or dilute alcohol solution ultrafiltration 1 time again, it is 0.15MPa that the pH value of feed liquid is controlled at 5. backwashing pressures, backwashing period is 0.5h, backwashing time is that 1min. is when replacing the method for recoil with ultrafiltration module use in parallel, wherein a cover or a few cover carry out normal ultrafiltration and distribute the recoil ultrafilter membrane of another set of or several grip assemblies of a part of filtrate, exchange is carried out behind the certain interval of time, work 10min, the recoil 30sec. Chemical cleaning cycle is 0.5 month, the Chemical cleaning medicament is 0.5%~4.0% sodium hydroxide, the mixed solution of 1.5% sodium hydroxide and 2% sodium hypochlorite, pH value is 10~12, and cleaning pressure is 0.05MPa. after cleaning with chemical, and the flushing of reuse water is near neutral.
Described ultrafiltrate concentrated obtain the Radix Salviae Miltiorrhizae extractum that relative density is 1.35~1.39 (55 ℃).Radix Notoginseng powder is broken into fine powder, mixes all with Radix Salviae Miltiorrhizae extractum, drying is made granule, sprays into Lignum Dalbergiae Odoriferae oil, is mixed with above-mentioned granule, is pressed into 1000, sugar coating, promptly.
Embodiment two
Crude drug adopts Radix Salviae Miltiorrhizae 558g, Radix Notoginseng 34g, Lignum Dalbergiae Odoriferae oil 8g.
Obtain the ethanol extract of Radix Salviae Miltiorrhizae with the ethanol extraction Radix Salviae Miltiorrhizae, carry out microfiltration, collect filtrate with ceramic membrane.Filtrate is that 80000 polysulfone membrane is carried out ultrafiltration with molecular cut off, and filter type adopts dead-end filtration.The operating condition of ultrafiltration technology is: the inlet pressure of ultrafiltration is 0.5Mpa, and the liquid outlet pressure ratio inlet pressure of ultrafiltration hangs down 0.25kPa.The ultrafiltration initial stage is adopted lower pressure, slowly boosts then; In ultra-filtration process, adopt the periodic pressure fluctuation, the pressure wave moment is 0.2Mpa.The feed liquid flow velocity is 4.0m/s, in the ultra-filtration process, adopts periodically flow fluctuation so that produce pulsating flow or non-stationary flow in membrane channels, the flow speed wave moment is 2.0m/s, feeds nitrogen in the ultrafiltration system discontinuous, forms the gas-liquid stream of pulses, cycle is that 2h ventilates once each 1 minute.Feed temperature is 50 ℃, when feed liquid stock solution is concentrated 1/5, adds water or dilute alcohol solution ultrafiltration 2 times again, and the pH value of feed liquid is controlled at 9.Backwashing pressure is 2.5MPa, and backwashing period is that 1.5h, backwashing time are 10min.When with the in parallel method of using alternately recoil of ultrafiltration module, wherein a cover or a few cover carry out normal ultrafiltration and distribute the recoil ultrafilter membrane of another set of or several grip assemblies of a part of filtrate, and exchange is carried out behind the certain interval of time, work 20min, recoil 3min.The Chemical cleaning cycle is 2 months, and the Chemical cleaning medicament is the mixed solution of 0.5%~4.0% sodium hydroxide, 1.5% sodium hydroxide and 2% sodium hypochlorite, and pH value is 10~12, and cleaning pressure is 1.0MPa.After cleaning with chemical, the flushing of reuse water is near neutral.
Described ultrafiltrate concentrated obtain the Radix Salviae Miltiorrhizae extractum that relative density is 1.35~1.39 (55 ℃).Radix Notoginseng powder is broken into fine powder, mixes all with Radix Salviae Miltiorrhizae extractum, drying is made granule, sprays into Lignum Dalbergiae Odoriferae oil; be mixed with above-mentioned granule, add 3% polyvidone alcoholic solution system soft material, cross 18 mesh sieve system granules, 60 ℃ of dryings 30~45 minutes, granulate; add Pulvis Talci, mixing fills in capsule, promptly.
Embodiment three
Crude drug adopts Radix Salviae Miltiorrhizae 360g, Radix Notoginseng 232g, Lignum Dalbergiae Odoriferae oil 8g.
Obtain the ethanol extract of Radix Salviae Miltiorrhizae with the ethanol extraction Radix Salviae Miltiorrhizae, get supernatant with dividing behind this extracting solution high speed centrifugation. with this liquid molecular cut off is that 50000 polysulfone membrane is carried out ultrafiltration, filter type adopts cross flow filter. and the operating condition of ultrafiltration technology is: the inlet pressure of ultrafiltration is 0.35Mpa, the low 0.20kPa. ultrafiltration initial stage of the liquid outlet pressure ratio inlet pressure of ultrafiltration is adopted lower pressure, slowly boosts then; In ultra-filtration process, the fluctuation of employing periodic pressure, the pressure wave moment is that 0.2Mpa. feed liquid flow velocity is 3.0m/s, in the ultra-filtration process, adopt periodically flow fluctuation so that in membrane channels, produce pulsating flow or non-stationary flow, the flow speed wave moment is 2.0m/s, feed nitrogen in the ultrafiltration system discontinuous, form the gas-liquid stream of pulses, cycle is that 2h ventilates once, each 1 minute. feed temperature is 40 ℃, when feed liquid stock solution is concentrated 1/8, add water or dilute alcohol solution ultrafiltration 2 times again, it is 2.5MPa that the pH value of feed liquid is controlled at the 7.5. backwashing pressure, backwashing period is 1.5h, backwashing time is that 10min. is when replacing the method for recoil with ultrafiltration module use in parallel, wherein a cover or a few cover carry out normal ultrafiltration and distribute the recoil ultrafilter membrane of another set of or several grip assemblies of a part of filtrate, exchange is carried out behind the certain interval of time, work 20min, the recoil 3min. Chemical cleaning cycle is 2 months, the Chemical cleaning medicament is 0.5%~4.0% sodium hydroxide, the mixed solution of 1.5% sodium hydroxide and 2% sodium hypochlorite, pH value is 10~12, and cleaning pressure is 1.0MPa. after cleaning with chemical, and the flushing of reuse water is near neutral.
Described ultrafiltrate concentrated obtain the Radix Salviae Miltiorrhizae extractum that relative density is 1.35~1.39 (55 ℃).Radix Notoginseng powder is broken into fine powder, mixes all with Radix Salviae Miltiorrhizae extractum, drying is made granule, sprays into Lignum Dalbergiae Odoriferae oil, is mixed with above-mentioned granule, is pressed into 1000, or sugar coating, promptly.
Embodiment four:
Crude drug adopts Radix Salviae Miltiorrhizae 500 grams, Radix Notoginseng 94 grams, Lignum Dalbergiae Odoriferae oil 6 grams.
The Radix Salviae Miltiorrhizae of coarse pulverization, pseudo-ginseng to extraction pot, are added 5 times of water gagings, decocted 2 hours, filter, filtering residue carries out second time and extracts, and adds 4 times of water gagings, fried in shallow oil 1 hour, and filtration, filtering residue discards, merging filtrate.Filtrate is that 6000 cellulose diacetate film carries out ultrafiltration with molecular cut off, and filter type adopts cross flow filter.The operating condition of ultrafiltration technology is: the inlet pressure of ultrafiltration is 0.1Mpa, and the liquid outlet pressure ratio inlet pressure of ultrafiltration hangs down 0.5kPa.The ultrafiltration initial stage is adopted lower pressure, slowly boosts then; In ultra-filtration process, adopt the periodic pressure fluctuation, the pressure wave moment is 0.1Mpa.The feed liquid flow velocity is 1.0m/s, in the ultra-filtration process, adopts periodically flow fluctuation so that produce pulsating flow or non-stationary flow in membrane channels, the flow speed wave moment is 1.0m/s, feeds nitrogen in the ultrafiltration system discontinuous, forms the gas-liquid stream of pulses, cycle is that 0.5h ventilates once each 1 minute.Feed temperature is 15 ℃, when feed liquid stock solution is concentrated 1/15, adds water or dilute alcohol solution ultrafiltration 1 time again, and the pH value of feed liquid is controlled at 5.Backwashing pressure is 0.15MPa, and backwashing period is that 0.5h, backwashing time are 1min.When with the in parallel method of using alternately recoil of ultrafiltration module, wherein a cover or a few cover carry out normal ultrafiltration and distribute the recoil ultrafilter membrane of another set of or several grip assemblies of a part of filtrate, and exchange is carried out behind the certain interval of time, work 10min, recoil 30sec.The Chemical cleaning cycle is 0.5 month, and the Chemical cleaning medicament is the mixed solution of 0.5%~4.0% sodium hydroxide, 1.5% sodium hydroxide and 2% sodium hypochlorite, and pH value is 10~12, and cleaning pressure is 0.05MPa.After cleaning with chemical, the flushing of reuse water is near neutral.
Described ultrafiltrate concentrated obtain the extractum that relative density is 1.32~1.40 (55 ℃), spray into Lignum Dalbergiae Odoriferae oil, mix homogeneously, with the lactose fluidisation, drying is made granule, promptly in the batch (-type) fluid bed.
Embodiment five
Crude drug adopts Radix Salviae Miltiorrhizae 290 grams, Radix Notoginseng 306 grams, Lignum Dalbergiae Odoriferae oil 6 grams.
The Radix Salviae Miltiorrhizae of coarse pulverization, pseudo-ginseng to extraction pot, are added 5 times of water gagings, decocted 2 hours, filter, filtering residue carries out second time and extracts, and adds 4 times of water gagings, fried in shallow oil 1 hour, and filtration, filtering residue discards, merging filtrate.Filtrate is that 80000 polysulfone membrane is carried out ultrafiltration with molecular cut off, and filter type adopts dead-end filtration.The operating condition of ultrafiltration technology is: the inlet pressure of ultrafiltration is 0.5Mpa, and the liquid outlet pressure ratio inlet pressure of ultrafiltration hangs down 0.25kPa.The ultrafiltration initial stage is adopted lower pressure, slowly boosts then; In ultra-filtration process, adopt the periodic pressure fluctuation, the pressure wave moment is 0.2Mpa.The feed liquid flow velocity is 4.0m/s, in the ultra-filtration process, adopts periodically flow fluctuation so that produce pulsating flow or non-stationary flow in membrane channels, the flow speed wave moment is 2.0m/s, feeds nitrogen in the ultrafiltration system discontinuous, forms the gas-liquid stream of pulses, cycle is that 2h ventilates once each 1 minute.Feed temperature is 50 ℃, when feed liquid stock solution is concentrated 1/5, adds water or dilute alcohol solution ultrafiltration 2 times again, and the pH value of feed liquid is controlled at 9.Backwashing pressure is 2.5MPa, and backwashing period is that 1.5h, backwashing time are 10min.When with the in parallel method of using alternately recoil of ultrafiltration module, wherein a cover or a few cover carry out normal ultrafiltration and distribute the recoil ultrafilter membrane of another set of or several grip assemblies of a part of filtrate, and exchange is carried out behind the certain interval of time, work 20min, recoil 3min.The Chemical cleaning cycle is 2 months, and the Chemical cleaning medicament is the mixed solution of 0.5%~4.0% sodium hydroxide, 1.5% sodium hydroxide and 2% sodium hypochlorite, and pH value is 10~12, and cleaning pressure is 1.0MPa.After cleaning with chemical, the flushing of reuse water is near neutral.
Described ultrafiltrate concentrated obtain the extractum that relative density is 1.32~1.40 (55 ℃), with this extractum and an amount of magnesium stearate mix homogeneously, spray into Lignum Dalbergiae Odoriferae oil, be mixed with above-mentioned granule, compacting is wrapped film-coat in flakes.
Embodiment six
Crude drug adopts Radix Salviae Miltiorrhizae 210 grams, Radix Notoginseng 380 grams, Lignum Dalbergiae Odoriferae oil 4 grams.
The Radix Salviae Miltiorrhizae of coarse pulverization, pseudo-ginseng to extraction pot, are added 5 times of water gagings, decocted 2 hours, filter, filtering residue carries out second time and extracts, and adds 4 times of water gagings, fried in shallow oil 1 hour, and filtration, filtering residue discards, merging filtrate.Filtrate is that 50000 polysulfone membrane is carried out ultrafiltration with molecular cut off, and filter type adopts cross flow filter.The operating condition of ultrafiltration technology is: the inlet pressure of ultrafiltration is 0.35Mpa, and the liquid outlet pressure ratio inlet pressure of ultrafiltration hangs down 0.20kPa.The ultrafiltration initial stage is adopted lower pressure, slowly boosts then; In ultra-filtration process, adopt the periodic pressure fluctuation, the pressure wave moment is 0.2Mpa.The feed liquid flow velocity is 3.0m/s, in the ultra-filtration process, adopts periodically flow fluctuation so that produce pulsating flow or non-stationary flow in membrane channels, the flow speed wave moment is 2.0m/s, feeds nitrogen in the ultrafiltration system discontinuous, forms the gas-liquid stream of pulses, cycle is that 2h ventilates once each 1 minute.Feed temperature is 40 ℃, when feed liquid stock solution is concentrated 1/8, adds water or dilute alcohol solution ultrafiltration 2 times again, and the pH value of feed liquid is controlled at 7.5.Backwashing pressure is 2.5MPa, and backwashing period is that 1.5h, backwashing time are 10min.When with the in parallel method of using alternately recoil of ultrafiltration module, wherein a cover or a few cover carry out normal ultrafiltration and distribute the recoil ultrafilter membrane of another set of or several grip assemblies of a part of filtrate, and exchange is carried out behind the certain interval of time, work 20min, recoil 3min.The Chemical cleaning cycle is 2 months, and the Chemical cleaning medicament is the mixed solution of 0.5%~4.0% sodium hydroxide, 1.5% sodium hydroxide and 2% sodium hypochlorite, and pH value is 10~12, and cleaning pressure is 1.0MPa.After cleaning with chemical, the flushing of reuse water is near neutral.
Described ultrafiltrate concentrated obtain the extractum that relative density is 1.32~1.40 (55 ℃),, spray into Lignum Dalbergiae Odoriferae oil, be mixed, be pressed into tablet with above-mentioned granule with this extractum and an amount of magnesium stearate mix homogeneously.
Embodiment seven
Crude drug adopts Radix Salviae Miltiorrhizae 450g, Radix Notoginseng 141g, Styrax 8g.
Obtain the ethanol extract of Radix Salviae Miltiorrhizae with the ethanol extraction Radix Salviae Miltiorrhizae, with this extracting liquid filtering, collect filtrate with gauze.Filtrate is that 6000 cellulose diacetate film carries out ultrafiltration with molecular cut off, and filter type adopts cross flow filter.The operating condition of ultrafiltration technology is: the inlet pressure of ultrafiltration is 0.1Mpa, and the liquid outlet pressure ratio inlet pressure of ultrafiltration hangs down 0.5kPa.The ultrafiltration initial stage is adopted lower pressure, slowly boosts then; In ultra-filtration process, adopt the periodic pressure fluctuation, the pressure wave moment is 0.1Mpa.The feed liquid flow velocity is 1.0m/s, in the ultra-filtration process, adopts periodically flow fluctuation so that produce pulsating flow or non-stationary flow in membrane channels, the flow speed wave moment is 1.0m/s, feeds nitrogen in the ultrafiltration system discontinuous, forms the gas-liquid stream of pulses, cycle is that 0.5h ventilates once each 1 minute.Feed temperature is 15 ℃, when feed liquid stock solution is concentrated 1/15, adds water or dilute alcohol solution ultrafiltration 1 time again, and the pH value of feed liquid is controlled at 5.Backwashing pressure is 0.15MPa, and backwashing period is that 0.5h, backwashing time are 1min.When with the in parallel method of using alternately recoil of ultrafiltration module, wherein a cover or a few cover carry out normal ultrafiltration and distribute the recoil ultrafilter membrane of another set of or several grip assemblies of a part of filtrate, and exchange is carried out behind the certain interval of time, work 10min, recoil 30sec.The Chemical cleaning cycle is 0.5 month, and the Chemical cleaning medicament is the mixed solution of 0.5%~4.0% sodium hydroxide, 1.5% sodium hydroxide and 2% sodium hypochlorite, and pH value is 10~12, and cleaning pressure is 0.05MPa.After cleaning with chemical, the flushing of reuse water is near neutral.
Described ultrafiltrate concentrated obtain the Radix Salviae Miltiorrhizae extractum that relative density is 1.35~1.39 (55 ℃).Radix Notoginseng powder is broken into fine powder, mixes all with Radix Salviae Miltiorrhizae extractum, drying is made granule, adds Styrax, is mixed, and is pressed into 1000, sugar coating, promptly.
Embodiment eight
Crude drug adopts Radix Salviae Miltiorrhizae 558g, Radix Notoginseng 34g, Styrax 8g.
Obtain the ethanol extract of Radix Salviae Miltiorrhizae with the ethanol extraction Radix Salviae Miltiorrhizae, carry out microfiltration, collect filtrate with ceramic membrane.Filtrate is that 80000 polysulfone membrane is carried out ultrafiltration with molecular cut off, and filter type adopts dead-end filtration.The operating condition of ultrafiltration technology is: the inlet pressure of ultrafiltration is 0.5Mpa, and the liquid outlet pressure ratio inlet pressure of ultrafiltration hangs down 0.25kPa.The ultrafiltration initial stage is adopted lower pressure, slowly boosts then; In ultra-filtration process, adopt the periodic pressure fluctuation, the pressure wave moment is 0.2Mpa.The feed liquid flow velocity is 4.0m/s, in the ultra-filtration process, adopts periodically flow fluctuation so that produce pulsating flow or non-stationary flow in membrane channels, the flow speed wave moment is 2.0m/s, feeds nitrogen in the ultrafiltration system discontinuous, forms the gas-liquid stream of pulses, cycle is that 2h ventilates once each 1 minute.Feed temperature is 50 ℃, when feed liquid stock solution is concentrated 1/5, adds water or dilute alcohol solution ultrafiltration 2 times again, and the pH value of feed liquid is controlled at 9.Backwashing pressure is 2.5MPa, and backwashing period is that 1.5h, backwashing time are 10min.When with the in parallel method of using alternately recoil of ultrafiltration module, wherein a cover or a few cover carry out normal ultrafiltration and distribute the recoil ultrafilter membrane of another set of or several grip assemblies of a part of filtrate, and exchange is carried out behind the certain interval of time, work 20min, recoil 3min.The Chemical cleaning cycle is 2 months, and the Chemical cleaning medicament is the mixed solution of 0.5%~4.0% sodium hydroxide, 1.5% sodium hydroxide and 2% sodium hypochlorite, and pH value is 10~12, and cleaning pressure is 1.0MPa.After cleaning with chemical, the flushing of reuse water is near neutral.
Described ultrafiltrate concentrated obtain the Radix Salviae Miltiorrhizae extractum that relative density is 1.35~1.39 (55 ℃).Radix Notoginseng powder is broken into fine powder, mixes all,, be mixed, add 3% polyvidone alcoholic solution system soft material, cross 18 mesh sieve system granules with above-mentioned granule with the Styrax porphyrize with Radix Salviae Miltiorrhizae extractum, 60 ℃ of dryings 30~45 minutes, granulate, the adding Pulvis Talci, mixing fills in capsule, promptly.
Embodiment nine
Crude drug adopts Radix Salviae Miltiorrhizae 360g, Radix Notoginseng 232g, Styrax 8g.
Obtain the ethanol extract of Radix Salviae Miltiorrhizae with the ethanol extraction Radix Salviae Miltiorrhizae, get supernatant dividing behind this extracting solution high speed centrifugation.With this liquid molecular cut off is that 50000 polysulfone membrane is carried out ultrafiltration, and filter type adopts cross flow filter.The operating condition of ultrafiltration technology is: the inlet pressure of ultrafiltration is 0.35Mpa, and the liquid outlet pressure ratio inlet pressure of ultrafiltration hangs down 0.20kPa.The ultrafiltration initial stage is adopted lower pressure, slowly boosts then; In ultra-filtration process, adopt the periodic pressure fluctuation, the pressure wave moment is 0.2Mpa.The feed liquid flow velocity is 3.0m/s, in the ultra-filtration process, adopts periodically flow fluctuation so that produce pulsating flow or non-stationary flow in membrane channels, the flow speed wave moment is 2.0m/s, feeds nitrogen in the ultrafiltration system discontinuous, forms the gas-liquid stream of pulses, cycle is that 2h ventilates once each 1 minute.Feed temperature is 40 ℃, when feed liquid stock solution is concentrated 1/8, adds water or dilute alcohol solution ultrafiltration 2 times again, and the pH value of feed liquid is controlled at 7.5.Backwashing pressure is 2.5MPa, and backwashing period is that 1.5h, backwashing time are 10min.When with the in parallel method of using alternately recoil of ultrafiltration module, wherein a cover or a few cover carry out normal ultrafiltration and distribute the recoil ultrafilter membrane of another set of or several grip assemblies of a part of filtrate, and exchange is carried out behind the certain interval of time, work 20min, recoil 3min.The Chemical cleaning cycle is 2 months, and the Chemical cleaning medicament is the mixed solution of 0.5%~4.0% sodium hydroxide, 1.5% sodium hydroxide and 2% sodium hypochlorite, and pH value is 10~12, and cleaning pressure is 1.0MPa.After cleaning with chemical, the flushing of reuse water is near neutral.
Described ultrafiltrate concentrated obtain the Radix Salviae Miltiorrhizae extractum that relative density is 1.35~1.39 (55 ℃).Radix Notoginseng powder is broken into fine powder, mixes all with Radix Salviae Miltiorrhizae extractum, drying is made granule, adds Styrax, is mixed, and is pressed into 1000, or sugar coating, promptly.
Embodiment ten
Crude drug adopts Radix Salviae Miltiorrhizae 500 grams, Radix Notoginseng 94 grams, Styrax 6 grams.
With the Radix Salviae Miltiorrhizae of coarse pulverization, pseudo-ginseng to extraction pot, add 5 times of water gagings, decocted 2 hours, filter, filtering residue carries out the second time and extracts, add 4 times of water gagings, fried in shallow oil 1 hour, filter, filtering residue discards, merging filtrate. and filtrate is that 6000 cellulose diacetate film carries out ultrafiltration with molecular cut off, and filter type adopts cross flow filter. and the operating condition of ultrafiltration technology is: the inlet pressure of ultrafiltration is 0.1Mpa, the low 0.5kPa. ultrafiltration initial stage of the liquid outlet pressure ratio inlet pressure of ultrafiltration is adopted lower pressure, slowly boosts then; In ultra-filtration process, the fluctuation of employing periodic pressure, the pressure wave moment is that 0.1Mpa. feed liquid flow velocity is 1.0m/s, in the ultra-filtration process, adopt periodically flow fluctuation so that in membrane channels, produce pulsating flow or non-stationary flow, the flow speed wave moment is 1.0m/s, feed nitrogen in the ultrafiltration system discontinuous, form the gas-liquid stream of pulses, cycle is that 0.5h ventilates once, each 1 minute. feed temperature is 15 ℃, when feed liquid stock solution is concentrated 1/15, add water or dilute alcohol solution ultrafiltration 1 time again, it is 0.15MPa that the pH value of feed liquid is controlled at 5. backwashing pressures, backwashing period is 0.5h, backwashing time is that 1min. is when replacing the method for recoil with ultrafiltration module use in parallel, wherein a cover or a few cover carry out normal ultrafiltration and distribute the recoil ultrafilter membrane of another set of or several grip assemblies of a part of filtrate, exchange is carried out behind the certain interval of time, work 10min, the recoil 30sec. Chemical cleaning cycle is 0.5 month, the Chemical cleaning medicament is 0.5%~4.0% sodium hydroxide, the mixed solution of 1.5% sodium hydroxide and 2% sodium hypochlorite, pH value is 10~12, and cleaning pressure is 0.05MPa. after cleaning with chemical, and the flushing of reuse water is near neutral.
Described ultrafiltrate concentrated obtain the extractum that relative density is 1.32~1.40 (55 ℃), add Styrax, mix homogeneously, with the lactose fluidisation, drying is made granule, promptly in the batch (-type) fluid bed.
Embodiment 11
Crude drug adopts Radix Salviae Miltiorrhizae 290 grams, Radix Notoginseng 306 grams, Styrax 6 grams.
The Radix Salviae Miltiorrhizae of coarse pulverization, pseudo-ginseng to extraction pot, are added 5 times of water gagings, decocted 2 hours, filter, filtering residue carries out second time and extracts, and adds 4 times of water gagings, fried in shallow oil 1 hour, and filtration, filtering residue discards, merging filtrate.Filtrate is that 80000 polysulfone membrane is carried out ultrafiltration with molecular cut off, and filter type adopts dead-end filtration.The operating condition of ultrafiltration technology is: the inlet pressure of ultrafiltration is 0.5Mpa, and the liquid outlet pressure ratio inlet pressure of ultrafiltration hangs down 0.25kPa.The ultrafiltration initial stage is adopted lower pressure, slowly boosts then; In ultra-filtration process, adopt the periodic pressure fluctuation, the pressure wave moment is 0.2Mpa.The feed liquid flow velocity is 4.0m/s, in the ultra-filtration process, adopts periodically flow fluctuation so that produce pulsating flow or non-stationary flow in membrane channels, the flow speed wave moment is 2.0m/s, feeds nitrogen in the ultrafiltration system discontinuous, forms the gas-liquid stream of pulses, cycle is that 2h ventilates once each 1 minute.Feed temperature is 50 ℃, when feed liquid stock solution is concentrated 1/5, adds water or dilute alcohol solution ultrafiltration 2 times again, and the pH value of feed liquid is controlled at 9.Backwashing pressure is 2.5MPa, and backwashing period is that 1.5h, backwashing time are 10min.When with the in parallel method of using alternately recoil of ultrafiltration module, wherein a cover or a few cover carry out normal ultrafiltration and distribute the recoil ultrafilter membrane of another set of or several grip assemblies of a part of filtrate, and exchange is carried out behind the certain interval of time, work 20min, recoil 3min.The Chemical cleaning cycle is 2 months, and the Chemical cleaning medicament is the mixed solution of 0.5%~4.0% sodium hydroxide, 1.5% sodium hydroxide and 2% sodium hypochlorite, and pH value is 10~12, and cleaning pressure is 1.0MPa.After cleaning with chemical, the flushing of reuse water is near neutral.
Described ultrafiltrate concentrated obtain the extractum that relative density is 1.32~1.40 (55 ℃), add Styrax, again with mannitol 30g, calcium disodium edetate 5g, distilled water 5ml, behind the said components mixing, lyophilization, packing, promptly.
Embodiment 12
Crude drug adopts Radix Salviae Miltiorrhizae 210 grams, Radix Notoginseng 380 grams, Styrax 4 grams.
With the Radix Salviae Miltiorrhizae of coarse pulverization, pseudo-ginseng to extraction pot, add 5 times of water gagings, decocted 2 hours, filter, filtering residue carries out the second time and extracts, add 4 times of water gagings, fried in shallow oil 1 hour, filter, filtering residue discards, merging filtrate. and filtrate is that 50000 polysulfone membrane is carried out ultrafiltration with molecular cut off, and filter type adopts cross flow filter. and the operating condition of ultrafiltration technology is: the inlet pressure of ultrafiltration is 0.35Mpa, the low 0.20kPa. ultrafiltration initial stage of the liquid outlet pressure ratio inlet pressure of ultrafiltration is adopted lower pressure, slowly boosts then; In ultra-filtration process, the fluctuation of employing periodic pressure, the pressure wave moment is that 0.2Mpa. feed liquid flow velocity is 3.0m/s, in the ultra-filtration process, adopt periodically flow fluctuation so that in membrane channels, produce pulsating flow or non-stationary flow, the flow speed wave moment is 2.0m/s, feed nitrogen in the ultrafiltration system discontinuous, form the gas-liquid stream of pulses, cycle is that 2h ventilates once, each 1 minute. feed temperature is 40 ℃, when feed liquid stock solution is concentrated 1/8, add water or dilute alcohol solution ultrafiltration 2 times again, it is 2.5MPa that the pH value of feed liquid is controlled at the 7.5. backwashing pressure, backwashing period is 1.5h, backwashing time is that 10min. is when replacing the method for recoil with ultrafiltration module use in parallel, wherein a cover or a few cover carry out normal ultrafiltration and distribute the recoil ultrafilter membrane of another set of or several grip assemblies of a part of filtrate, exchange is carried out behind the certain interval of time, work 20min, the recoil 3min. Chemical cleaning cycle is 2 months, the Chemical cleaning medicament is 0.5%~4.0% sodium hydroxide, the mixed solution of 1.5% sodium hydroxide and 2% sodium hypochlorite, pH value is 10~12, and cleaning pressure is 1.0MPa. after cleaning with chemical, and the flushing of reuse water is near neutral.
Described ultrafiltrate concentrated obtain the extractum that relative density is 1.32~1.40 (55 ℃), with this extractum and an amount of magnesium stearate mix homogeneously, the adding Styrax is mixed, and is pressed into tablet.

Claims (11)

1. a Chinese medicine composition for the treatment of angina pectoris is characterized in that, it is by Radix Salviae Miltiorrhizae 20%~97%, Radix Notoginseng 2%~79%, and Lignum Dalbergiae Odoriferae oil or Styrax 0.2%~3% are prepared from through following steps:
(a) with Radix Salviae Miltiorrhizae, panax mixed or make water extract or alcohol extract separately;
(b) described extracting solution being carried out predefecation handles;
(c) further described extracting solution is carried out hyperfiltration treatment;
(d) ultrafiltrate is concentrated, add Lignum Dalbergiae Odoriferae oil or Styrax, make preparation according to a conventional method;
The operating procedure condition of described hyperfiltration treatment is as follows:
The inlet pressure of ultrafiltration is 0.1~0.5MPa, and the liquid outlet pressure ratio inlet pressure of ultrafiltration hangs down 0.25~0.5kPa; Feed temperature is 15~50 ℃; The pH value of feed liquid is controlled at 5~9; When feed liquid stock solution is concentrated 1/15~1/5, add water or dilute alcohol solution ultrafiltration 1~2 time again;
In the process of described ultrafiltration separately or unite the following method that adopts: periodic pressure fluctuation, periodically flow fluctuation, feed noble gas off and on; Wherein the pressure wave moment of periodic pressure fluctuation is 0.1~0.2Mpa, and periodically the flow speed wave moment of flow fluctuation is 1.0~2.0 meter per seconds, feeds noble gas off and on and be ventilation in 0.5 hour~2 hours once, each 1 minute.
2. Chinese medicine composition as claimed in claim 1 is characterized in that, the percentage by weight of described raw material is:
Radix Salviae Miltiorrhizae 63.0%~94%,
Radix Notoginseng 4.0%~35.0%,
Lignum Dalbergiae Odoriferae oil or Styrax 0.5%~2.0%.
3. Chinese medicine composition as claimed in claim 2 is characterized in that, the percentage by weight of described raw material is:
Radix Salviae Miltiorrhizae 75.2%~90%,
Radix Notoginseng 9%~23.5%,
Lignum Dalbergiae Odoriferae oil or Styrax 0.5%~1.3%.
4. Chinese medicine composition as claimed in claim 1 is characterized in that, described alcohol extract is to be selected from the following lower alcohol or the extracting solution of its mixture: methanol, ethanol, normal propyl alcohol, isopropyl alcohol, n-butyl alcohol, isobutanol.
5. Chinese medicine composition as claimed in claim 1 is characterized in that, described alcohol extract is an ethanol extract.
6. Chinese medicine composition as claimed in claim 1 is characterized in that, what described step (a) obtained is the ethanol extract of Radix Salviae Miltiorrhizae.
7. Chinese medicine composition as claimed in claim 1 is characterized in that, what described step (a) obtained is the aqueous extract that Radix Salviae Miltiorrhizae and panax mixed are made.
8. Chinese medicine composition as claimed in claim 1 is characterized in that described predefecation is treated to coarse filtration adsorption clarification, adsorption clarification-high speed centrifugation, coarse filtration-microfiltration or coarse filtration-precipitate with ethanol.
9. Chinese medicine composition as claimed in claim 1, it is characterized in that, the used ultrafilter membrane of described hyperfiltration treatment is selected from: cellulose diacetate film, three cellulose acetate membrane, cyanoethyl cellulose film, polysulfone membrane, sulfonated polysulfone membrane, poly (ether sulfone) film, sulfonated polyether sulfone film, polysulfonamides film, phenolphthalein side group polyarylsulfone (PAS) film, polyvinylidene fluoride film, polyacrylonitrile film, polyimide film, cellulose membrane, methyl methacrylate-acrylonitrile copolymer film, polyacrylonitrile/cellulose diacetate blend film, the dynamically ultrafilter membrane that forms, and the Modified Membrane of above-mentioned film; The molecular cut off of its ultrafilter membrane is 6000~80000.
10. Chinese medicine composition as claimed in claim 9, it is characterized in that, described ultrafilter membrane is selected from: cellulose diacetate film, three cellulose acetate membrane, polysulfone membrane, sulfonated polysulfone membrane, poly (ether sulfone) film, sulfonated polyether sulfone film, polysulfonamides film, polyvinylidene fluoride film, polyacrylonitrile film; The molecular cut off of its ultrafilter membrane is 10000~70000.
11. Chinese medicine composition as claimed in claim 1, it is characterized in that described preparation contains any or more than one are selected from following pharmaceutics adjuvant: starch, dextrin, lactose, microcrystalline Cellulose, hydroxypropyl methylcellulose, Polyethylene Glycol, magnesium stearate, micropowder silica gel, xylitol, lactose, glucose, glycine, mannitol.
CN 200410072949 2004-11-26 2004-11-26 Medicine for treating coronary heart disease Active CN1778344B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 200410072949 CN1778344B (en) 2004-11-26 2004-11-26 Medicine for treating coronary heart disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200410072949 CN1778344B (en) 2004-11-26 2004-11-26 Medicine for treating coronary heart disease

Publications (2)

Publication Number Publication Date
CN1778344A CN1778344A (en) 2006-05-31
CN1778344B true CN1778344B (en) 2010-05-12

Family

ID=36768881

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200410072949 Active CN1778344B (en) 2004-11-26 2004-11-26 Medicine for treating coronary heart disease

Country Status (1)

Country Link
CN (1) CN1778344B (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1362048A (en) * 2002-01-24 2002-08-07 华南师范大学 Visible light induced delayed lighting no-damage tumor imaging method and equipment
CN1470255A (en) * 2002-07-22 2004-01-28 王智民 Preparation extracted from the root of red-rooted solvia and pseudo-ginseng and its compound preparation and medical use

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1362048A (en) * 2002-01-24 2002-08-07 华南师范大学 Visible light induced delayed lighting no-damage tumor imaging method and equipment
CN1470255A (en) * 2002-07-22 2004-01-28 王智民 Preparation extracted from the root of red-rooted solvia and pseudo-ginseng and its compound preparation and medical use

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
刘洪谦,屈凌波,贾金付.生脉饮口服液超滤技术研究.中草药27 4.1996,27(4),209-211.
刘洪谦,屈凌波,贾金付.生脉饮口服液超滤技术研究.中草药27 4.1996,27(4),209-211. *
李淑莉,刘振丽,宋志前.超滤法在中药制剂纯化工艺中的应用研究进展.中药材26 12.2003,26(12),898-902.
李淑莉,刘振丽,宋志前.超滤法在中药制剂纯化工艺中的应用研究进展.中药材26 12.2003,26(12),898-902. *
郝莉.超滤法制备丹参注射液的工艺改进.中草药27 8.1996,27(8),471.
郝莉.超滤法制备丹参注射液的工艺改进.中草药27 8.1996,27(8),471. *
黄伟文,梁云,邵霞.超滤法制备中药注射液的质量研究.水处理技术14 2.1988,14(2),87-91.
黄伟文,梁云,邵霞.超滤法制备中药注射液的质量研究.水处理技术14 2.1988,14(2),87-91. *

Also Published As

Publication number Publication date
CN1778344A (en) 2006-05-31

Similar Documents

Publication Publication Date Title
CN1778340B (en) Chinese medicine composition for treating coronary heart disease and angina cordis
CN1778335B (en) Chinese medicine for treating coronary heart disease and angina cordis
CN1778333B (en) Chinese medicine for treating coronary heart disease and angina cordis
CN101085013B (en) Traditional Chinese medicinal composition containing red sage root, safflower, radix astragali and dalbergia oil and its preparation
CN1778343B (en) Medicine dropping pill for treating coronary heart disease
CN1778337B (en) Preparation of compound Danshen Root tablet
CN1778338B (en) Chinese medicine composition for treating coronary heart disease and angina cordis
CN1778344B (en) Medicine for treating coronary heart disease
CN1778322B (en) Chinese medicine for treating cardiovascular disease
CN1778352B (en) Chinese medicine composition for treating cardiovascular disease
CN1778342B (en) Chinese medicine composition for treating coronary heart disease
CN1778334B (en) Chinese Medicine dropping pill for treating coronary heart disease and angina cordis
CN1778353B (en) Chinese medicine dropping ball for treating cardiovascular disease
CN1778339B (en) Medicine dropping pill for treating coronary heart disease and angina cordis
CN1778346B (en) Medicine for treating coronary heart disease
CN1778345B (en) Chinese medicine dropping pill for treating coronary heart disease
CN1778341B (en) Medicine dropping pill for treating coronary heart disease and angina cordis
CN1778326B (en) Medicine for treating cardiovascular disease
CN1778354B (en) Chinese medicine dropping ball for coronary heart disease and angina cordis
CN1778327B (en) Medicine dropping pill for treating cardiovascular disease
CN1778347B (en) Chinese medicine dropping pill for treating coronary heart disease
CN101088522B (en) Chinese medicine composition containing red sage, notoginseng and musk or muskone and its prepn
CN101084993B (en) Medicinal composition containing dalbergia and storax, preparation method and preparation
CN101085056B (en) Traditional Chinese medicinal composition containing red sage root, radix paeoniae rubrathe and dalbergia oil and its preparation
CN101085016B (en) Traditional Chinese medicinal composition containing red sage root, notoginseng and ginseng or codonopsis pilosula and its preparation

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C56 Change in the name or address of the patentee

Owner name: TASLY PHARMACEUTICAL GROUP CO., LTD.

Free format text: FORMER NAME: TIANJIN TASLY PHARM. CO., LTD.

CP01 Change in the name or title of a patent holder

Address after: 300402 Tianjin City, Beichen science and Technology Park of Beichen Xinyi Road Liaohe Road No. 1 white

Patentee after: Tasly Pharmaceutical Group Co., Ltd.

Address before: 300402 Tianjin City, Beichen science and Technology Park of Beichen Xinyi Road Liaohe Road No. 1 white

Patentee before: Tianjin Tianshili Pharmaceutical Co., Ltd.

CP01 Change in the name or title of a patent holder

Address after: 300402 Tianjin City, Beichen science and Technology Park of Beichen Xinyi Road Liaohe Road No. 1 white

Patentee after: Tasly Pharmaceutical Group Limited by Share Ltd

Address before: 300402 Tianjin City, Beichen science and Technology Park of Beichen Xinyi Road Liaohe Road No. 1 white

Patentee before: Tasly Pharmaceutical Group Co., Ltd.

CP01 Change in the name or title of a patent holder